Literature DB >> 23666824

Cuprizone-induced demyelination as a tool to study remyelination and axonal protection.

Adib Zendedel1, Cordian Beyer, Markus Kipp.   

Abstract

In the brain of multiple sclerosis (MS) patients, the conduction block of axons due to demyelination and inflammation underlies early neurological symptoms, whereas axonal transection accounts for permanent deficits occurring during later disease stages. The beneficial function of myelin for the protection of the axonal compartment and network stability between neurons has been shown in numerous studies. Thus, rapid and adequate remyelination is an important factor for axonal patronage during neuroinflammatory conditions. In this review article, we discuss frequently used experimental in vivo and in vitro animal models to examine remyelination and repair in MS. The focus of the discussion is the relevance of the toxin model 'cuprizone' to study the pathology of demyelination and the physiology of remyelination. This also includes recent findings in this animal model which implicate that axonal damage is an ongoing process independent of the initiation of endogenous remyelination.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23666824     DOI: 10.1007/s12031-013-0026-4

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  49 in total

1.  Characterisation of microglia during de- and remyelination: can they create a repair promoting environment?

Authors:  Elke Verena Voss; Jelena Škuljec; Viktoria Gudi; Thomas Skripuletz; Refik Pul; Corinna Trebst; Martin Stangel
Journal:  Neurobiol Dis       Date:  2011-09-21       Impact factor: 5.996

2.  Corticosteroids impair remyelination in the corpus callosum of cuprizone-treated mice.

Authors:  T Clarner; A Parabucki; C Beyer; M Kipp
Journal:  J Neuroendocrinol       Date:  2011-07       Impact factor: 3.627

3.  Platelet-derived growth factor promotes repair of chronically demyelinated white matter.

Authors:  Adam C Vana; Nicole C Flint; Norah E Harwood; Tuan Q Le; Marcus Fruttiger; Regina C Armstrong
Journal:  J Neuropathol Exp Neurol       Date:  2007-11       Impact factor: 3.685

4.  Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.

Authors:  Thomas Skripuletz; Maren Lindner; Alexandra Kotsiari; Niklas Garde; Jantje Fokuhl; Franziska Linsmeier; Corinna Trebst; Martin Stangel
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

Review 5.  The cuprizone animal model: new insights into an old story.

Authors:  Markus Kipp; Tim Clarner; Jon Dang; Sjef Copray; Cordian Beyer
Journal:  Acta Neuropathol       Date:  2009-09-18       Impact factor: 17.088

6.  Remyelination protects axons from demyelination-associated axon degeneration.

Authors:  K A Irvine; W F Blakemore
Journal:  Brain       Date:  2008-05-18       Impact factor: 13.501

7.  The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination.

Authors:  Rashad Hussain; Abdel M Ghoumari; Bartosz Bielecki; Jérôme Steibel; Nelly Boehm; Philippe Liere; Wendy B Macklin; Narender Kumar; René Habert; Sakina Mhaouty-Kodja; François Tronche; Regine Sitruk-Ware; Michael Schumacher; M Said Ghandour
Journal:  Brain       Date:  2013-01       Impact factor: 13.501

8.  Functional recovery of callosal axons following demyelination: a critical window.

Authors:  D K Crawford; M Mangiardi; X Xia; H E López-Valdés; S K Tiwari-Woodruff
Journal:  Neuroscience       Date:  2009-10-02       Impact factor: 3.590

9.  Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus.

Authors:  Akvile Norkute; Andrea Hieble; Alena Braun; Sonja Johann; Tim Clarner; Werner Baumgartner; Cordian Beyer; Markus Kipp
Journal:  J Neurosci Res       Date:  2009-05-01       Impact factor: 4.164

10.  Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations.

Authors:  Florian Then Bergh; Tania Kümpfel; Erina Schumann; Ulrike Held; Michaela Schwan; Mirjana Blazevic; Axel Wismüller; Florian Holsboer; Alexander Yassouridis; Manfred Uhr; Frank Weber; Martin Daumer; Claudia Trenkwalder; Dorothee P Auer
Journal:  BMC Neurol       Date:  2006-05-23       Impact factor: 2.474

View more
  42 in total

Review 1.  Oligodendrocyte-microglia cross-talk in the central nervous system.

Authors:  Laura Peferoen; Markus Kipp; Paul van der Valk; Johannes M van Noort; Sandra Amor
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

2.  Anatomical Distribution of Cuprizone-Induced Lesions in C57BL6 Mice.

Authors:  Johannes Goldberg; Tim Clarner; Cordian Beyer; Markus Kipp
Journal:  J Mol Neurosci       Date:  2015-06-12       Impact factor: 3.444

3.  Inducible Expression of a Truncated Form of Tau in Oligodendrocytes Elicits Gait Abnormalities and a Decrease in Myelin: Implications for Selective CNS Degenerative Diseases.

Authors:  Patrizia LoPresti
Journal:  Neurochem Res       Date:  2015-09-22       Impact factor: 3.996

4.  Changes in the axo-glial junctions of the optic nerves of cuprizone-treated mice.

Authors:  Wataru Kojima; Kensuke Hayashi
Journal:  Histochem Cell Biol       Date:  2018-02-19       Impact factor: 4.304

5.  Regulatory effect of triiodothyronine on brain myelination and astrogliosis after cuprizone-induced demyelination in mice.

Authors:  Adib Zendedel; Iraj Ragerdi Kashani; Maryam Azimzadeh; Parichehr Pasbakhsh; Negar Omidi; Abolfazl Golestani; Cordian Beyer; Tim Clarner
Journal:  Metab Brain Dis       Date:  2016-01-04       Impact factor: 3.584

6.  Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.

Authors:  Stefan Esser; Larissa Göpfrich; Kai Bihler; Eugenia Kress; Stella Nyamoya; Simone C Tauber; Tim Clarner; Matthias B Stope; Thomas Pufe; Markus Kipp; Lars-Ove Brandenburg
Journal:  Mol Neurobiol       Date:  2017-12-29       Impact factor: 5.590

7.  Protective effects of melatonin against mitochondrial injury in a mouse model of multiple sclerosis.

Authors:  Iraj Ragerdi Kashani; Zahra Rajabi; Mohammad Akbari; Gholamreza Hassanzadeh; Alireza Mohseni; Mohammadtaha Kouchakinejad Eramsadati; Kheirollah Rafiee; Cordian Beyer; Markus Kipp; Adib Zendedel
Journal:  Exp Brain Res       Date:  2014-05-06       Impact factor: 1.972

8.  The Effect of Stereotactic Injections on Demyelination and Remyelination: a Study in the Cuprizone Model.

Authors:  Laura Salinas Tejedor; Tanja Wostradowski; Stefan Gingele; Thomas Skripuletz; Viktoria Gudi; Martin Stangel
Journal:  J Mol Neurosci       Date:  2017-01-26       Impact factor: 3.444

9.  A cord blood monocyte-derived cell therapy product accelerates brain remyelination.

Authors:  Arjun Saha; Susan Buntz; Paula Scotland; Li Xu; Pamela Noeldner; Sachit Patel; Amy Wollish; Aruni Gunaratne; Tracy Gentry; Jesse Troy; Glenn K Matsushima; Joanne Kurtzberg; Andrew E Balber
Journal:  JCI Insight       Date:  2016-08-18

10.  Resveratrol Promotes Remyelination in Cuprizone Model of Multiple Sclerosis: Biochemical and Histological Study.

Authors:  Heba R Ghaiad; Mohammed M Nooh; Maha M El-Sawalhi; Amira A Shaheen
Journal:  Mol Neurobiol       Date:  2016-04-11       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.